Search research articles
Contact Us
Filters
Showing results (941-950 of 969) with videos related to
Page
of 97
Sort By:
Cancer Research
|
April 7, 2017
Modulation of Bax and mTOR for Cancer Therapeutics
Rui Li, Chunyong Ding, Jun Zhang, et al.
Cell
|
May 5, 2022
Systematic discovery of mutation-directed neo-protein-protein interactions in cancer
Xiulei Mo, Qiankun Niu, Andrey A Ivanov, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
October 3, 2013
Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic study
Nabil F Saba, Selwyn J Hurwitz, Scott A Kono, et al.
Nature Communications
|
May 9, 2013
Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation
Taro Hitosugi, Lu Zhou, Jun Fan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2015
A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non-Small Cell Lung Cancer
Taofeek K Owonikoko, Suresh S Ramalingam, Daniel L Miller, et al.
Open Research Europe
|
June 23, 2025
Responsible research impact: Ethics for making a difference
Eric Allen Jensen, Mark S Reed, James Daybell, et al.
Cancer Cell
|
July 24, 2018
MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation
Lingtao Jin, Jaemoo Chun, Chaoyun Pan, et al.
Molecular Cell
|
February 4, 2014
Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex
Jun Fan, Changliang Shan, Hee-Bum Kang, et al.
Cancer Discovery
|
May 16, 2012
The BATTLE trial: personalizing therapy for lung cancer
Edward S Kim, Roy S Herbst, Ignacio I Wistuba, et al.
Cell Metabolism
|
January 17, 2017
Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth
Siyuan Xia, Ruiting Lin, Lingtao Jin, et al.
Page
of 97
Search research articles
Search
Showing results (941-950 of 969) with videos related to
Sort By:
Page
of 97
Cancer Research
|
April 7, 2017
Modulation of Bax and mTOR for Cancer Therapeutics
Rui Li, Chunyong Ding, Jun Zhang, et al.
Cell
|
May 5, 2022
Systematic discovery of mutation-directed neo-protein-protein interactions in cancer
Xiulei Mo, Qiankun Niu, Andrey A Ivanov, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
October 3, 2013
Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic study
Nabil F Saba, Selwyn J Hurwitz, Scott A Kono, et al.
Nature Communications
|
May 9, 2013
Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation
Taro Hitosugi, Lu Zhou, Jun Fan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2015
A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non-Small Cell Lung Cancer
Taofeek K Owonikoko, Suresh S Ramalingam, Daniel L Miller, et al.
Open Research Europe
|
June 23, 2025
Responsible research impact: Ethics for making a difference
Eric Allen Jensen, Mark S Reed, James Daybell, et al.
Cancer Cell
|
July 24, 2018
MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation
Lingtao Jin, Jaemoo Chun, Chaoyun Pan, et al.
Molecular Cell
|
February 4, 2014
Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex
Jun Fan, Changliang Shan, Hee-Bum Kang, et al.
Cancer Discovery
|
May 16, 2012
The BATTLE trial: personalizing therapy for lung cancer
Edward S Kim, Roy S Herbst, Ignacio I Wistuba, et al.
Cell Metabolism
|
January 17, 2017
Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth
Siyuan Xia, Ruiting Lin, Lingtao Jin, et al.
Page
of 97